Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 03-Oct 2018. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 98413101000001118 | Fluticasone furoate 92micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler (Colorama Pharmaceuticals Ltd) 30 dose (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 98413201000001113 | Fluticasone furoate 92micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler (Colorama Pharmaceuticals Ltd) 30 dose | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Fluticasone furoate 92micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler (Colorama Pharmaceuticals Ltd) 30 dose | Is a | Fluticasone furoate 92micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler 30 dose | false | Inferred relationship | Existential restriction modifier | ||
| Fluticasone furoate 92micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler (Colorama Pharmaceuticals Ltd) 30 dose | Has AMP | Fluticasone furoate 92micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler (Colorama Pharmaceuticals Ltd) | false | Inferred relationship | Existential restriction modifier | ||
| Fluticasone furoate 92micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler (Colorama Pharmaceuticals Ltd) 30 dose | Has excipient | Excipient not declared | false | Inferred relationship | Existential restriction modifier | ||
| Fluticasone furoate 92micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler (Colorama Pharmaceuticals Ltd) 30 dose | VMP prescribing status (attribute) | VMP valid as a prescribable product | false | Inferred relationship | Existential restriction modifier | ||
| Fluticasone furoate 92micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler (Colorama Pharmaceuticals Ltd) 30 dose | VMP non-availability indicator | Available | false | Inferred relationship | Existential restriction modifier | ||
| Fluticasone furoate 92micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler (Colorama Pharmaceuticals Ltd) 30 dose | Has specific active ingredient | Vilanterol | false | Inferred relationship | Existential restriction modifier | ||
| Fluticasone furoate 92micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler (Colorama Pharmaceuticals Ltd) 30 dose | Has specific active ingredient | Fluticasone furoate | false | Inferred relationship | Existential restriction modifier | ||
| Fluticasone furoate 92micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler (Colorama Pharmaceuticals Ltd) 30 dose | Has dispensed dose form | Conventional release powder for inhalation | false | Inferred relationship | Existential restriction modifier | ||
| Fluticasone furoate 92micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler (Colorama Pharmaceuticals Ltd) 30 dose | Legal category | Prescription only medicine - legal category (qualifier value) | false | Inferred relationship | Existential restriction modifier | ||
| Fluticasone furoate 92micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler (Colorama Pharmaceuticals Ltd) 30 dose | Discontinued indicator | Never discontinued | false | Inferred relationship | Existential restriction modifier | ||
| Fluticasone furoate 92micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler (Colorama Pharmaceuticals Ltd) 30 dose | Is a | Actual medicinal product pack | false | Inferred relationship | Existential restriction modifier | ||
| Fluticasone furoate 92micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler (Colorama Pharmaceuticals Ltd) 30 dose | Discontinued indicator | Discontinued AMPP(qualifier value) | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR